We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » More Hospira Pumps Susceptible to Cyberattack, DHS Warns

More Hospira Pumps Susceptible to Cyberattack, DHS Warns

June 12, 2015

The Department of Homeland Security issued an alert that more Hospira infusion systems may be susceptible to cyberattacks that could lead to over- or under-infusion of medications.

The latest memo from Homeland Security’s Industrial Control Systems Cyber Emergency Response Team, released Wednesday, warns that a hacker with low skills could access the systems remotely and change the medication dosage.

The warning affects Hospira’s Plum A+, Plum A+3 and Symbiq infusion systems.

ICS-CERT says the devicemaker is communicating with customers on steps to mitigate the vulnerability and is releasing its Plum 360 infusion system, which is not vulnerable to the same cyberattacks.

Homeland Security is recommending that healthcare providers change a default password on the systems, monitor and log all network traffic attempting to access the systems, maintain layered security and isolate all medical devices from the internet and untrusted systems.

An independent researcher, Billy Rios, first identified the vulnerabilities in the LifeCare system in May 2014, according to the ICS-CERT advisory.

In May, ICS-CERT and the FDA issued warnings for Hospira’s LifeCare PCA Infusion System.

At the time, Hospira said it had developed a new version that will not be susceptible to hackers and that the FDA is reviewing its 510(k) submission.

To read the ICS-CERT advisory, go to www.fdanews.com/06-15-Hospira.pdf. — John Bechtel

Postmarket Safety

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • WhiteHouse.gif

    President Biden Issues Executive Order on U.S. Supply Chain

  • roche.gif

    Priority Healthcare Settles Diabetes Test Lawsuit with Roche for $43 Million

  • Effective text

    Pfizer/BioNTech Vaccine Equally Effective for All Age Groups, Israeli Study Says

  • Siemens Healthineers logo

    Siemens Healthineers’ COVID-19 Antigen Lab Test Receives CE Mark

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing